Is NGEN or NRIX more undervalued in 2026?

CirclFi compares NervGen Pharma Corp. (NGEN) and Nurix Therapeutics, Inc. (NRIX) using 13 institutional-grade valuation models. NGEN has a Quality of Company score of 3.1/10 while NRIX scores 6.4/10.

Which is a better buy — NGEN or NRIX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do NGEN and NRIX valuations compare?

NGEN at $2.07 and NRIX at $17.76 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

NGEN vs NRIX Valuation Comparison 2026 — Intrinsic Value Analysis

NGEN

Pharmaceutical Preparations

NervGen Pharma Corp.

Quality

3.1

out of 10

Value Trap

—

Price

$2.07

Last close

Models

6/13

Active

NRIX

Pharmaceutical Preparations

Nurix Therapeutics, Inc.

Quality

6.4

out of 10

Value Trap

SAFE

Price

$17.76

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	NGEN Fair Value	NGEN Upside	NRIX Fair Value	NRIX Upside
Bayesian DCF	Intrinsic	$1.09	-47.3%	$4.54	-74.4%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$0.12	-94.2%	$4.75	-73.2%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for NGEN vs NRIX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

NGEN vs NRIX — Which Stock Is More Undervalued?

NRIX scores higher with a 6.4/10 quality rating vs NGEN's 3.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing NervGen Pharma Corp. (NGEN) and Nurix Therapeutics, Inc. (NRIX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

NGEN currently trades at $2.07 with a QOC of 3.1/10, while NRIX trades at $17.76 with a QOC of 6.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).